uniQure
QURE
161 hedge funds and large institutions have $789M invested in uniQure in 2022 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 69 increasing their positions, 49 reducing their positions, and 29 closing their positions.
400% more call options, than puts
Call options by funds: $37.4M | Put options by funds: $7.5M
41% more repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 49
3.08% more ownership
Funds ownership: 86.93% → 90% (+3.1%)
4% more capital invested
Capital invested by funds: $756M → $789M (+$32.5M)
4% less funds holding
Funds holding: 168 → 161 (-7)
21% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 29
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$15.2M |
| 2 |
State Street
Boston,
Massachusetts
|
+$14.7M |
| 3 |
Holocene Advisors
New York
|
+$14.5M |
| 4 |
BlackRock
New York
|
+$12.6M |
| 5 |
IBT
International Biotechnology Trust
London,
United Kingdom
|
+$11.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
-$13.3M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$10.6M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$9.76M |
| 4 |
Morgan Stanley
New York
|
-$7.18M |
| 5 |
PFM
Privium Fund Management
Amsterdam,
Netherlands
|
-$4.68M |
QURE Hedge Fund Activity: Q3 2022 in Review
161 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in uniQure (QURE) for Q3 2022, worth a combined $789M — up 4.3% from $756M a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of QURE and 23 opened new positions — a net loss of 6 holders — while 49 trimmed existing stakes and 69 added.
The largest buyer was OrbiMed, adding an estimated $15.2M. The largest seller was Balyasny Asset Management, exiting entirely with an estimated $13.3M sold.
- 161 institutional investors held uniQure (QURE) as of Q3 2022, down from 168 in Q2 2022.
- Funds reported $789M of uniQure stock for Q3 2022, up 4.3% quarter-over-quarter.
- 23 funds opened new uniQure positions in Q3 2022 and 29 closed out, a net change of -6 holders.
- The largest uniQure buyer in Q3 2022 was OrbiMed, an estimated $15.2M added.
- The largest uniQure seller in Q3 2022 was Balyasny Asset Management, an estimated $13.3M sold.
Based on aggregated 13F filings for Q3 2022.